Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (21-30 of 286) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 24, 2012
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro dataNitin Ohri, Adam P Dicker, Yaacov Richard Lawrence
Expert Review of Neurotherapeutics|October 8, 2010
From survival to survivorship: late side effects become an issue in high-grade gliomaYaacov R Lawrence, Wenyin Shi, Adam P Dicker
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung CancerNeal S McCall, Adam P Dicker, Bo Lu
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Utilizing 10-Year Results From the American Board of Radiology Clinical Examination to Identify Areas for Programmatic ImprovementRobert B Den, Marlene Folino, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|June 19, 2013
In reply to Franken and BarendsenYaacov Richard Lawrence, Adam P Dicker, Nitin Ohri
The Canadian Journal of Urology|August 16, 2012
Late toxicity rates following definitive radiotherapy for prostate cancerNitin Ohri, Adam P Dicker, Timothy N Showalter
Brachytherapy|May 17, 2005
Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate baseLesley Hughes, Frank M Waterman, Adam P Dicker
JAMA|July 6, 2021
Immune Checkpoint Inhibitor Therapy ToxicitiesHeather S L Jim, Hans Knoop, Adam P Dicker
Brachytherapy|April 6, 2004
A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapyAshish B Patel, Frank M Waterman, Adam P Dicker
Seminars in Oncology|June 29, 2013
Introduction: the changing landscape of prostate cancerAdam P Dicker, Leonard G Gomella, William Kevin Kelly
Pageof 29

Showing results (21-30 of 286) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|January 24, 2012
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro dataNitin Ohri, Adam P Dicker, Yaacov Richard Lawrence
Expert Review of Neurotherapeutics|October 8, 2010
From survival to survivorship: late side effects become an issue in high-grade gliomaYaacov R Lawrence, Wenyin Shi, Adam P Dicker
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung CancerNeal S McCall, Adam P Dicker, Bo Lu
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Utilizing 10-Year Results From the American Board of Radiology Clinical Examination to Identify Areas for Programmatic ImprovementRobert B Den, Marlene Folino, Adam P Dicker
International Journal of Radiation Oncology, Biology, Physics|June 19, 2013
In reply to Franken and BarendsenYaacov Richard Lawrence, Adam P Dicker, Nitin Ohri
The Canadian Journal of Urology|August 16, 2012
Late toxicity rates following definitive radiotherapy for prostate cancerNitin Ohri, Adam P Dicker, Timothy N Showalter
Brachytherapy|May 17, 2005
Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate baseLesley Hughes, Frank M Waterman, Adam P Dicker
JAMA|July 6, 2021
Immune Checkpoint Inhibitor Therapy ToxicitiesHeather S L Jim, Hans Knoop, Adam P Dicker
Brachytherapy|April 6, 2004
A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapyAshish B Patel, Frank M Waterman, Adam P Dicker
Seminars in Oncology|June 29, 2013
Introduction: the changing landscape of prostate cancerAdam P Dicker, Leonard G Gomella, William Kevin Kelly
Pageof 29